BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9251731)

  • 1. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
    Ojala AE; Lanning FP; Pääkkö E; Lanning BM
    Med Pediatr Oncol; 1997 Oct; 29(4):260-5. PubMed ID: 9251731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study.
    Ojala AE; Pääkkö E; Lanning FP; Lanning M
    Med Pediatr Oncol; 1999 Jan; 32(1):11-7. PubMed ID: 9917747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow changes on MRI in children with acute lymphoblastic leukaemia 5 years after treatment.
    Ojala AE; Pääkkö E; Lanning FP; Harila-Saari AH; Lanning BM
    Clin Radiol; 1998 Feb; 53(2):131-6. PubMed ID: 9502090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
    Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
    BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread osteonecrosis in children with leukemia revealed by whole-body MRI.
    Miettunen PM; Lafay-Cousin L; Guilcher GM; Nettel-Aguirre A; Moorjani V
    Clin Orthop Relat Res; 2012 Dec; 470(12):3587-95. PubMed ID: 23008023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
    te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
    J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
    Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
    J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bony morbidity in children treated for acute lymphoblastic leukemia.
    Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
    J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Whole-body MR imaging in children with suspected osteonecrosis after intensive chemotherapy: preliminary results].
    Beer M; Stenzel M; Girschick H; Schlegel PG; Darge K
    Rofo; 2008 Mar; 180(3):238-45. PubMed ID: 18278731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Levien MG
    Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
    [No Abstract]   [Full Text] [Related]  

  • 11. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
    Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
    Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avascular necrosis of bone following an intensified chemotherapy regimen including high dose steroids.
    Thornton MJ; O'Sullivan G; Williams MP; Hughes PM
    Clin Radiol; 1997 Aug; 52(8):607-12. PubMed ID: 9285421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
    Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
    Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis in children with acute lymphoblastic leukemia.
    Kunstreich M; Kummer S; Laws HJ; Borkhardt A; Kuhlen M
    Haematologica; 2016 Nov; 101(11):1295-1305. PubMed ID: 27742768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
    Padhye B; Dalla-Pozza L; Little D; Munns C
    Cancer Med; 2016 May; 5(5):960-7. PubMed ID: 26792372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A
    Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
    Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
    Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
    Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
    Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on Co-ALL-07-03 trial: a single centre analysis.
    Kuhlen M; Moldovan A; Krull K; Meisel R; Borkhardt A
    Klin Padiatr; 2014 May; 226(3):154-60. PubMed ID: 24710762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.